• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  12/11/2008
Trade Name:  PegIntron
Generic or Proper Name (*):  Peginterferon alfa-2b
Indications Studied:  Co-administered with ritonavir to treat chronic hepatitis C in patients 3 years of age and older with compensated liver disease previously untreated with interferon alpha
Therapeutic Category:  Antiviral
Ages Studied:  3 - 17 years
Study #:  1
Study Type:  Efficacy/Safety/Pharmacokinetic/Tolerability
Study Design:  Open Label/Traditional Pharmacokinetic
No Patients:  107
No Centers:  22
No Countries:  9